NDC 66277-337 - Epuris
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66277-337
- Package NDCs from labels
- 66277-337-10, 66277-337-30
- Manufacturer
- Galephar Pharmaceutical Research Inc. | Galephar Pharmaceutical Research Inc
- Effective date
- 2024-12-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Epuris - Galephar Pharmaceutical Research Inc. | Galephar Pharmaceutical Research Inc | Galephar Pharmaceutical Research Inc. | Galephar Pharmaceutical Research Inc | 2024-12-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66277-337-10 | Epuris | 10 in 1 BLISTER PACK | CAPSULE | 10 | 2 | |
| 66277-337-30 | Epuris | 3 in 1 BOX | CAPSULE | 3 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clinolipid | OLIVE OIL AND SOYBEAN OIL | Baxter Healthcare Corporation | ae98eb03-c0e7-49d1-b024-77968e3d9d6e | 2025-07-24 | Warnings, Adverse reactions | 241ATL177A |
| Isotretinoin | ISOTRETINOIN | Zydus Lifesciences Limited | 245898e5-3a61-4d6a-8375-8b3a8b7364ac | 2025-06-04 | EH28UP18IF | |
| 289d5b9f-62bc-7112-e063-6394a90a3326 | d6ba7a44-ca13-e001-e053-2995a90afe0c | 2024-12-06 | 289d5b9f-62bc-7112-e063-6394a90a3326 d6ba7a44-ca13-e001-e053-2995a90afe0c | |||
| Isotretinoin | ISOTRETINOIN | Zydus Lifesciences Limited | dae33df0-386c-4db5-9759-7096e770ed17 | 2024-11-30 | EH28UP18IF | |
| Isotretinoin | ISOTRETINOIN | Mayne Pharma | 0114567b-3bac-490d-b9eb-03a6c5d90935 | 2024-06-26 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Sun Pharmaceutical Industries, Inc. | b44200ba-6672-4ea7-b151-7caec3f53c9c | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Amneal Pharmaceuticals NY LLC | 9f1c8971-c6dc-4708-848b-5cee50b6c32a | 2023-08-24 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Mayne Pharma | 72867c88-070f-4608-bfef-cc5225ebce6d | 2022-11-03 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Mayne Pharma | ebe1b3e3-1013-4cf6-bdc8-2baa3dc26e16 | 2022-11-03 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Isotretinoin | ISOTRETINOIN | Upsher-Smith Laboratories, LLC | ff1edbb8-ac0e-4563-9c2a-94385ce055e3 | 2022-10-24 | Boxed warning, Warnings, Adverse reactions | EH28UP18IF |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare CORP | 069460a5-3e9a-428f-b2dc-3405690f4fd7 | 2022-07-25 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | 55609586-f0b4-42e6-8dd9-cd090afb5dca | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | a69c82da-15ba-4d4d-8d7f-871dc3981eb8 | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I. V. FAT EMULSION | Baxter Healthcare Corporation | dd269651-30e8-43f0-880f-484346eaafeb | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | cbd3396e-6b85-41bf-82d2-940beba86686 | 2019-01-09 | Boxed warning, Warnings, Adverse reactions | 241ATL177A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.